Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| YMAB (Y mAbs Therapeutics) | NA | -33.82% | -16.22% | -26.52% | NA | NA | NA | … | … |
Data as of 09/16/2025, Common starting date is 09/24/2018
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| YMAB (Y mAbs Therapeutics) | 09/24/2018 | 09/16/2025 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | 0.35 | -33.82 | -16.22 | -26.52 | NA | NA | NA | … | … | 9.96 | 17.30 | 39.75 | -69.90 | -67.26 | 58.43 | 53.64 | -24.58 |
| Sharpe Ratio | NA | -0.39 | -0.19 | -0.31 | NA | NA | NA | … | … | 0.11 | 0.15 | 0.43 | -0.52 | -1.06 | 0.79 | 0.91 | -0.78 |
| Standard Deviation(%) | NA | 95.47 | 102.90 | 93.39 | NA | NA | NA | … | … | 106.46 | 72.04 | 83.27 | 136.46 | 63.21 | 73.68 | 57.15 | 85.36 |
| Draw Down(%) | NA | 76.80 | 81.34 | 94.78 | NA | NA | NA | … | … | 55.45 | 57.20 | 53.00 | 84.75 | 70.15 | 59.80 | 31.08 | 46.72 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 09/16/2025, Common starting date is 09/24/2018
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| YMAB (Y mAbs Therapeutics) |
-51.25%
Oct 2019 – Oct 2022 |
-36.36%
Jun 2020 – Jun 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| YMAB (Y mAbs Therapeutics) |
0.00%
Oct 2018 – Oct 2021 |
-5.06%
Feb 2019 – Feb 2024 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart